CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 56 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,788 | -59.2% | 392 | -49.7% | 0.00% | – |
| Q2 2023 | $26,467 | +52.0% | 780 | +61.2% | 0.00% | – |
| Q1 2023 | $17,414 | -19.3% | 484 | 0.0% | 0.00% | – |
| Q4 2022 | $21,571 | +978.6% | 484 | +456.3% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 87 | -13.0% | 0.00% | – |
| Q2 2022 | $3,000 | -83.3% | 100 | -90.0% | 0.00% | – |
| Q4 2020 | $18,000 | +20.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | – | 1,000 | +1165.8% | 0.00% | – |
| Q3 2019 | $0 | – | 79 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 79 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 761,398 | $41,108,000 | 10.12% |
| Opaleye Management Inc. | 985,000 | $53,045,000 | 9.91% |
| VR Adviser, LLC | 1,098,174 | $59,290,000 | 7.62% |
| ACUTA CAPITAL PARTNERS, LLC | 337,500 | $18,222,000 | 6.43% |
| TSP Capital Management Group, LLC | 271,429 | $14,654,000 | 5.00% |
| Ghost Tree Capital, LLC | 255,000 | $13,767,000 | 4.03% |
| COMMODORE CAPITAL LP | 248,207 | $13,401,000 | 3.53% |
| RTW INVESTMENTS, LP | 3,908,947 | $211,044,000 | 3.18% |
| Ikarian Capital, LLC | 791,600 | $42,741,000 | 3.01% |
| Redmile Group, LLC | 3,043,298 | $164,308,000 | 2.87% |